telemedicine
One month ago, I wrote about how a Supreme Court case with little to do with digital health on the surface could turn out to be a game changer for telemedicine.
Teladoc, a large and fast-growing video visits company based in Dallas, Texas, has taken the first step toward filing an initial public offering, according to a statement from the company.
Patients are overwhelmingly satisfied with dermatology consults via Google Glass, even preferring them to consultations over the phone, according to a feasibility study recently published in JAMA dermatology.
Some 30 percent of health professionals are dissatisfied with the technology their organization uses for secure communication, according to a Harris Poll survey of 955 providers.
San Francisco-based direct-to-consumer remote dermatology care service Spruce has raised $15 million from Kleiner, Perkins, Caufield and Byers, Google Ventures, Baseline Ventures, and Cowboy Ventures.
A recent Supreme Court decision could have a profound impact on the ability of state medical boards to prevent telemedicine companies from offering their services, according to some experts familiar with the case.
Earlier this month Washington DC-based telehealth startup, Pacify, has raised $1.
Sixty four percent of patients are willing to participate in a video visit with a doctor, according to an online Harris Poll survey of 2,019 adults aged 18 and up conducted in December 2014.